The diversity of TNBC, the lack of hormonal receptors, and less effective targeted therapy greatly increase the chance for early relapse, increase metastatic potential, and diminish overall survival in comparison to other breast cancer subtypes [3]. This evidence concerns the gene NR4A1 and breast cancer.